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arteriesAbstract Background: Cyanotic congenital heart disease (CCHD) accounts for 25% of congenital
heart defects and has a high morbidity and mortality in neonates.
Objective: The aim of this work was to study clinical profile and available therapeutic modalities
used in the management of CCHD.
Subjects and methods: This was a prospective study carried out for a period of one year, starting
from January 2011, and included 50 neonates admitted to neonatal intensive care unit (NICU) of
Sohag University Hospital, Sohag, Upper Egypt. All included patients were subjected to thorough
clinical history, full clinical examination, initial and frequent measurement of oxygen saturation by
pulse oximetry, blood gas analysis, and echocardiography. Also, therapeutic modalities used in
management of CCHD were noted.
Results: 50 neonates were diagnosed as having CCHD, out of them 39 (78%) were males with
male to female ratio 3.55:1. The mean age of presentation was 11.78 ± 9.4 days. CCHD frequency
was found to be 9.5% (50/524) in our NICU population. The most common type of CCHD was
d-transposition of great arteries (D-TGA) (66%) followed by complex CCHD (12%) and hypoplas-
tic left heart syndrome (HLHS) (12%), whereas the less common type was hypoplastic right ventri-
cle (2%). All cases presented with central cyanosis and needed medical treatment whereas balloon
atrial septostomy was performed in 26% of cases. Seventy-four percent of cases were improved and
referred to higher centers while 26% were expired during hospital stay.
Conclusion: CCHD is a leading cause of neonatal morbidity and mortality. CCHD frequency
was significant (9.5%) in our study population with D-TGA being the commonest type. Majority
of neonates with CCHD showed survival with suitable management. Early diagnosis and referral
to pediatric cardiac center for proper management will improve the outcome. Neonatologists and
pediatric cardiologists should be familiar with diagnosis and management of CCHD.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ospital,
Table 1 The possible risk factors of CCHD.
Risk factors No. (%)
Consanguinity 17 34
Family history 6 12
Maternal infection 8 16
Maternal drugs 10 20
CCHD, cyanotic congenital heart disease.
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Congenital heart disease (CHD) can be defined as an anatomic
malformation of the heart or large vessels which occurs during
intrauterine development, irrespective of the age at presenta-
tion [1]. It is the most common congenital problem in children
representing nearly 25% of all congenital malformations [2].
The incidence of CHD in different studies varies from about
4/1000 to 50/1000 live birth [3]. Congenital cyanotic heart
disease (CCHD) accounts for 25% of all cases of CHD [4].
Etiology of most cases of CHD is thought to be multifacto-
rial and they result from a combination of genetic predisposi-
tion and environmental factors [5]. The majority of genetic
causes of CHD are sporadic genetic changes or large chromo-
somal abnormalities [6]. Environmental factors for the devel-
opment of CHD include maternal disease and drug exposure
[7]. Positive family history is considered one of the most com-
mon risk factors for CHD [8].
The neonates with CCHD may present with cyanosis, car-
diovascular collapse, and congestive heart failure or combina-
tions of these presentations. Pure versions of specific defects
may present in some patients, but many neonates have various
combinations of defects [9]. Echocardiography, with Doppler
and color Doppler has become the primary diagnostic tool
for CCHD. In addition, it reduces the requirement for invasive
studies such as cardiac catheterization [10].
There is lack of data about spectrum of CCHD in neonates
in our locality. The aim of the study was to describe clinical
profile and available therapeutic modalities used in the man-
agement of CCHD in neonatal intensive care unit (NICU) at
Sohag University hospital, Upper Egypt.
2. Subjects and methods
2.1. Study design
This was a prospective, cross sectional, descriptive study car-
ried out for a period of one year, starting from January
2011, at neonatal intensive care unit (NICU) in Sohag Univer-
sity Hospital, Sohag, Upper Egypt. Sohag University Hospital
is a tertiary care referral hospital for patients from hospitals in
Sohag and Qena Governorates. Admitted neonates diagnosed
with cyanotic congenital heart disease (CCHD) were included
in the study.
2.2. Exclusion criteria
Neonates diagnosed as acyanotic congenital heart disease,
other causes of central cyanosis and persistent pulmonary
hypertension of neonates (PPHN) were excluded from the
study.
2.3. Ethical consideration
The protocol of the study was approved by Research Ethics
Committee at Sohag Faculty of Medicine. Informed consent
was obtained from parents of all enrolled subjects. The work
has been carried out in accordance with The Code of Ethics
of The World Medical Association (Declaration of Helsinki)
for experiments on humans.Please cite this article in press as: Abou-Taleb A et al., Clinical profile of cyanotic con
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All neonates included in this work were subjected to the fol-
lowing: thorough clinical history, full clinical examination, ini-
tial and frequent measurement of oxygen saturation by pulse
oximetry and arterial blood gas (ABG) analysis. Echocardiog-
raphy has been performed by a single pediatric cardiologist at
NICU using M-mode, Two-dimensional Color Doppler car-
diac imaging, 7 MHz, 5 MHz-transducers frequency by the
mean of Two-dimensional ECHO (Vivid 3). All therapeutic
modalities used in management of CCHD were documented.
2.5. Statistical analysis
The data were subjected to statistical analysis and tabulation
using SPSS version 18. P value is considered significant if less
than 0.05 then the results were presented to fulfill the objec-
tives of the study.
3. Results
During the 1-year study period, total admissions in our NICU
were 524. Out of them 50 neonates were diagnosed with cyan-
otic congenital heart disease (CCHD) and included in the
study. CCHD frequency was found to be 9.5% (50/524) in
our NICU population. Out of CCHD cases, 39 (78%) were
males with male to female ratio 3.55:1. Their age of presenta-
tion ranged from 2 to 28 days with mean age of presentation
11.78 ± 9.4 days. The most common presenting symptoms
were central cyanosis (100%), followed by respiratory distress
(82%), then feeding difficulties (62%). The less common symp-
toms were generalized convulsions (12%) and bleeding ten-
dency (4%).
The commonest risk factors encountered among the studied
neonates were positive parental consanguinity (34%), followed
by maternal drug intake in 1st trimester of pregnancy (20%).
These drugs included antibiotics, analgesics, antipyretics or
folic acid. Maternal infection during 1st trimester and positive
family history of CCHD, were found in 16% and 12%, respec-
tively (Table 1).
Arterial blood gas (ABG) analysis at time of admission
revealed metabolic acidosis in 56% of cases and normal PH
in 44% of cases.
Hypoxemia by pulse oximetry, [peripheral capillary oxygen
saturation (SpO2) < 85%], was detected in 96% of cases.
However by ABG analysis, all cases were hypoxemic [partial
pressure of arterial oxygen (PaO2) < 85 mmHg]. P value
between pulse oximetry and ABG was 0.137.genital heart disease in neonatal intensive care unit at Sohag University Hospital,
16.01.003
Table 3 Different therapeutic modalities.
Therapeutic modalities No. %
I. Medical treatment 50 100.0
II. Balloon atrial septostomy 13 26.0
III. Mechanical ventilation 13 26.0
IV. Oxygen therapy 26 52.0
Table 4 Complications.
Complications No. %
Heart failure 25 50
Brain insult Extensive infarction 1 2.0
Intracranial hemorrhage 4 8.0
Meningitis 1 2.0
Polycythemia 4 8.0
Severe chest infection 21 42.0
Signs of septicemia 21 42.0
Table 5 Outcome of different types of CCHD.
Outcome Dead Live P value
No. % No. %
D-TGA 0 0.0 33 100.0 0.000
Hypoplastic right ventricle 0 0.0 1 100.0
Pulmonary atresia 2 100.0 0 0.0
Complex CCHD 5 83.3 1 16.7
Single ventricle 0 0.0 2 100.0
HLHS 6 100.0 0 0.0
D-TGA, d-transposition of great arteries; CCHD, cyanotic
congenital heart disease; HLHS, hypoplastic left heart syndrome.
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cases, the most frequent type of CCHD was d-transposition
of great arteries (D-TGA) (33/50,66%), followed by complex
CCHD (6/50,12%) and hypoplastic left heart syndrome
(HLHS) (6/50,12%) then single ventricle (2/50,4%) and pul-
monary atresia (2/50,4%), whereas the less common type
was hypoplastic right ventricle (1/50,2%). Complex CCHD
included 3 cases of D-TGA with pulmonary atresia and 3 cases
of D-TGA with tricuspid atresia (Table 2).
All cases needed medical treatment in the form of one or
more of the following [Prostaglandin E1 (PGE1) infusion,
antifailure, inotropes, antibiotics, vitamin K or sodium bicar-
bonate]. Balloon atrial septostomy was performed in
(13/50,26%) of cases. Thirteen neonates (26%) required
mechanical ventilation while oxygen therapy was used in
(26/50,52%) of cases (Table 3).
In our study, heart failure was the most common complica-
tion (50%), followed by severe chest infection (42%) and signs
of septicemia (42%) while the less common complications were
brain insult (12%) and polycythemia (8%) (Table 4).
Regarding the outcome of studied cases, 37 (74%) cases
were improved and referred to a higher center as Abo-
Elreesh Children Hospital, Cairo University to complete their
treatment. Thirteen (26%) babies expired during hospital stay.
There was no mortality among the cases with D-TGA,
hypoplastic right ventricle and single ventricle, while mortality
rate was 100% in cases of pulmonary atresia and hypoplastic
left heart syndrome (HLHS), and (5/6,83.3%) in cases with
complex CCHD (Table 5).
As regards the possible causes of death, the most common
causes were irreversible shock (16%), followed by delayed
referral to a higher center (8%) and the less common cause
was central apnea (2%).
4. Discussion
Congenital heart disease (CHD) has already been known as an
important cause of significant morbidity and mortality in
neonatal period. Neonatal unit is the best place for screening
and diagnosis of CHD [11]. The objective of the present study
was to describe the clinical profile and available therapeutic
modalities used in the management of CCHD in NICU at
Sohag University hospital. During the one year study period
50 neonates were diagnosed with cyanotic congenital heartTable 2 Echocardiography findings.
ECHO Frequency (%)
D-TGA 33 (66)
Complex CCHD
D-TGA+ TA 3 (6.0)
D-TGA+ PA 3 (6.0)
Hypoplastic right ventricle 1 (2.0)
Pulmonary atresia 2 (4.0)
Single ventricle 2 (4.0)
HLHS 6 (12.0)
Total 50 (100)
D-TGA, d-transposition of great arteries; TA, tricuspid atresia;
PA, pulmonary atresia; HLHS, hypoplastic left heart syndrome;
CCHD, cyanotic congenital heart disease.
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found to be 9.5% (50/524) in our NICU population. Shima
et al. [12] reported that the occurrence rate of CHD is nearly
4.5% of admitted neonates in neonatal intensive care unit. In
another study, it was found to be 4% of NICU population
[13]. Ekici et al. [14], in a prospective study for one year, found
that the incidence of CHD in all admitted neonates to NICU
to be 3.49%. Our frequency rate is higher than other studies;
this may be due to the reason that our NICU is the only ter-
tiary care unit and a referral unit for critically sick neonates
from 2 Governorates (Sohag and Quena).
In the present study of CCHD, there was male predomi-
nance with male to female ratio 3.55:1. This is consistent with
a recent study in Pakistan (50 males/37 females) [15]. Also,
Zahid et al. [16], in Peshawar, Pakistan, stated a male to female
ratio of 1.3:1. Shah et al., in Nepal, found that male to female
ratio was 1.5:1 [17]. However, our finding is not similar to that
reported in Saudi Arabia [18] and Iceland [19], where the fre-
quency was the same for males and females while in a study
in Nigeria, there was female predominance in CHD [20]. This
can be explained by differences in race and ethnic groups.
In our study the most common presenting symptoms were
central cyanosis (100%), followed by respiratory distress
(82%), and feeding difficulties (62%) in the form of poor suck-
ling, poor feeding and interrupted feeding whereas the lessenital heart disease in neonatal intensive care unit at Sohag University Hospital,
16.01.003
4 A. Abou-Taleb et al.common presentations were generalized convulsions (12%)
and bleeding tendency (4%). This was in agreement with other
studies done by Humayun and Atiq [21] and Dorfman et al.
[22]. However in a study by Masood et al. [23] more than
two-thirds of cases presented with respiratory distress while
cyanosis was present in 40% of cases. This difference may be
due to difference in age of studied cases.
Positive parental consanguinity was encountered in 34% of
our cases. This in line with the study done by Settin et al. [24]
in Mansoura Locality, Egypt, where positive parental consan-
guinity was found in 18.8% of CHD cases. Also, Bassili et al.
[25] reported high rate of positive parental consanguinity as a
risk factor for CHD. In addition, in a study done in Iran, par-
ental consanguinity was found in 39.6% of cases with CHD
[26].
Other risk factors for the development of CCHD in our
study were maternal drug intake (20%), maternal infection
during 1st trimester of pregnancy (16%) and positive family
history of CCHD (12%). This came in agreement with other
studies [27,28]. However positive family history was found
only in 2.2% of neonates with CHD in a study done by
Hussain et al. [15].
In our study 96% of cases were hypoxemic (SpO2 < 85%)
by pulse oximetry. Meanwhile all cases were hypoxemic
(PaO2 < 85 mmHg) by ABG analysis. P value between pulse
oximetry and ABG was P= 0.137. So pulse oximetry is a
good, easy, non invasive, and cheap method for early diagnosis
and detection of degree of hypoxemia but it is less accurate and
should be confirmed by ABG analysis. This was in line with a
study done by Riede et al. [29] as they found that pulse oxime-
try was a good screening tool for detection of duct-dependent
pulmonary circulation, as it has detected 100% of cases.
Transposition of great arteries (D-TGA) was the most fre-
quent type of CCHD in our patients with a frequency of 66%,
followed by HLHS (12%) and complex CCHD (12%), mean-
while the less common types were single ventricle (4%) and
pulmonary atresia (4%) followed by hypoplastic right ventricle
(2%). Our work was in agreement with studies done by Islam
et al. [28] and Farooqui et al. [30]. However in studies done by
Patra et al. [4], Hussain et al. [15], Humayun and Atiq, [21] and
Zahid et al. [16], the most common types of CCHD were
Tetralogy of Fallot (TOF) followed by D-TGA. This differ-
ence can be because of inclusion of only neonates in our study
while other studies included older children and usually Tetral-
ogy of Fallot presents after few months of life.
All cases needed medical treatment in the form of one or
more of the following (Prostaglandin E1 ‘‘PGE1”, antifailure,
inotropes antibiotics, vitamin K, sodium bicarbonate). Balloon
atrial septostomy was performed in 26% of cases. Thirteen
neonates (26%) required mechanical ventilation while oxygen
therapy was used in 52% of cases. The majority of our cases
(74%) were improved by using these modalities. Neutze
et al. [31] stated that PGE1 infusions have been used to
increase ductal patency in 11 cases with CCHD, all of them
showed a satisfactory increase in oxygen saturation attributed
to dilatation of the ductus. In a study done by Kovacikova
et al. [32], continuous infusion of PGE1 was administered in
84.6%, dopamine in 30%, and Na bicarbonate was used in
34.6% of the cases. Meanwhile 30.8% of cases were mechani-
cally ventilated and 34% were referred to tertiary hospital.
In our work the most common complications were heart
failure (50%), followed by severe chest infection (42%), signsPlease cite this article in press as: Abou-Taleb A et al., Clinical profile of cyanotic con
Upper Egypt, Egypt J Med Hum Genet (2016), http://dx.doi.org/10.1016/j.ejmhg.20of septicemia (42%), while the less common complications
were brain insult (12%) and polycythemia (8%). This was in
accordance with other studies [17,21].
Regarding the outcome of studied cases, 74% of cases were
improved and then referred to a higher center as Abo-Elreesh
Children Hospital, Cairo University to complete their treat-
ment. Thirteen patients (26%) expired during hospital stay.
The mortality rate of 26% is more than that reported in other
studies where Shah et al. [17], in Nepal, reported 20% mortal-
ity rate among patients with CHD and also, Jacobs et al. [33],
in a study from Hong Kong reported 20% mortality in cyan-
otic heart disease patients. However, the mortality rate is
higher in the study by Humayun and Atiq [21], where mortal-
ity rate was 36.4%. The difference may be due difference in the
study population and the availability of cardiac facilities.
The most common causes of death were irreversible shock
(16%) mostly carcinogenic shock and septic shock, followed
by delayed referral to a higher center (8%) and the less com-
mon cause was central apnea (2%) due to extensive cerebral
infarction and severe ICH. In the study done by Humayun
and Atiq [21], the causes of death were surgical complications
in 2 (4.5%) cases and medical problems in 14 (31.8%) babies
such as sepsis and pneumonia and associated extra-cardiac
malformations.5. Conclusion
Congenital heart disease (CHD) is the most common congeni-
tal malformation presenting in the neonatal period with cyan-
otic defects representing 25% of all cases of CHD. Cyanotic
congenital heart disease (CCHD) is a leading cause of neonatal
morbidity and mortality. CCHD frequency was found to be
9.5% in our study population. Transposition of great arteries
was the commonest CCHD diagnosed in our patients. Majority
of neonates with CCHD showed survival with suitable manage-
ment. Early diagnosis and referral to pediatric cardiac center
for proper management will improve the outcome. Significant
proportion of studied cases had complex cyanotic heart defects,
so neonatologists and pediatric cardiologists should be familiar
with diagnosis and management of these defects.6. Limitations of the study
Our study had some limitations as the study included only a
single center. Also the study was for only one year duration,
this was not an enough period for catching all the cases with
CCHD and we do not know the outcome of neonates referred
to the cardiac centers for surgery. It is a hospital based study
and may not reflect the true incidence or prevalence of CCHD
in our community as the study included only neonates admit-
ted in NICU at Sohag University Hospital.Conflict of interest
We have no conflict of interest to declare.
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